I.ntegrin/hgand binding evokes tyrosine phosphorylation of various proteins. We reported previously that a 105 kD protein (ppl05) was tyrosine phosphorylated by the engagement of [31 integrins in T lymphocytes. We show here that ppl05 is a novel p130Cas (Crk-associated substrate)-related protein. Deduced amino acid sequence revealed that ppl05 contains conserved motifs with p130Cas, and both ppl05 and p130Cas bind to focal adhesion kinase (pp125FAK) and Crk. However, ppl05 has a clearly distinct structure from p130Cas, and ppl05 is preferentially expressed in lymphocytes, whereas p130Cas is expressed in adherent cells. With these findings, we designate ppl05 as Cas-L, lymphocyte-type Cas. Furthermore, we demonstrate that integrin/hgand binding results in the recruitment of Crk, Nck, and SHPTP2 to ppl05. These findings further define the roles of ppl05/Cas-L and pp125FAK in the integrin-mediated signaling pathways. ever, a 105-kD tyrosine-phosphorylated protein (ppl05) has not been identified.
T he [31 integrins play an important role in the interaction between T cells and the surrounding extracellular matrix (1) and may aid lymphocyte migration into tissues (2) . In addition to their role in cell adhesion, recent studies have clearly shown that integrins transduce signals into the interior of T lymphocytes and other types of cells (3) . We and others have shown that the binding of T cells to the extracellular matrix through [31 integrins provides costimulatory signals for T cell proliferation (4) (5) (6) (7) (8) (9) . We also identified protein tyrosine phosphorylation as a [31 integrin-mediated biochemical signal occurring before T cell proliferation. The engagement of [31 integrin molecules induced tyrosine phosphorylation of 140-, 120-, 110-105-, 80-70-, 60-55-, and 45-kD proteins in peripheral T cells (10) (11) (12) . Several tyrosine-phosphorylated proteins have been identified, such as phospholipase C (PLC)-~/ (pp140), focal adhesion kinase (pp125FAK [pp120]) l, paxillin (pp70), p59Fyn/p56Lck (pp60-55), and mitogen-activated protein (MAP) kinase (pp45) (10) . How1Abbreviations used in this paper: Cas, Crk-associated substrate; CT, COOH-terminal domain; FAK, focal adhesion kinase; FN, fibronectin; GST, glutathione-S-transferase; PLL, poly-t-lysine; SH, Src homology; SOS, son ofsevenless.
M. Minegishi, K. Tachibana, and T. Sato contributed equally to this work. ever, a 105-kD tyrosine-phosphorylated protein (ppl05) has not been identified.
ppl05 is a protein that we first identified in T lymphoblastoid H9 cells as well as peripheral T cells (11) . ppl05 is a 105-kD protein that is tyrosine phosphorylated by the engagement of 0L4131 integrin. Our previous studies demonstrated that ppl05 is distinct from pp125FAK, although both ppl05 and pp125FAK are tyrosine phosphorylated via similar kinetics by the engagement of oL4[~l integrin in H9 ceils (12) . Given the fact that ppl05 is one of the major proteins that is tyrosine phosphorylated by [31 integrin stimulation in peripheral T cells, ppl05 may play an important role in [31 integfin-mediated signaling in T cells.
Recently, Sakai et al. (13) cloned the cDNA ofpl30Cas (Crk-associated substrate), p130Cas was originally identified as a tyrosine-phosphorylated 130 kD protein in the p60 v-src-or p47V-Crk-transformed fibroblasts. The deduced amino acid sequence of pl30Cas revealed that p130Cas contained one Src homology (SH) 3 domain in the NH zterminal region and multiple putative binding sites of SH2 domains. Tyrosine phosphorylated pl30Cas bound to Crk, and the deduced amino acid sequence of p130Cas contained multiple binding motifs of the Crk SH2 domain. Crk can bind to guanine nucleotide-releasing factors son of sevenless (SOS) and C3G by the SH3 domain of Crk (14, 15) . SOS and C3G are involved in the activation of Kas and P, aplA, respectively (16, 17) . These findings suggested that tyrosine-phosphorylated p130Cas is involved in the activation of Ras family proteins by the association with Crk. Moreover, we demonstrated that p130Cas is tyrosine phosphorylated by [31 integrin stimulation in fibroblasts (18) . O n the other hand, Poke and Hanks (19) reported that p130Cas bound to pp125FAK via its SH3 domain.
In this study, we demonstrate that pp 105 is a novel Casrelated protein that is expressed in lymphocytes. W e also show the predicted structure o f p p l 0 5 based on an isolated cDNA. Furthermore, we show that ppl05 binds to FAK and other signaling molecules, including Crk. These findings further suggest the role of ppl05 in the [31 integrinmediated signaling pathways.
Materials and Methods
Cell Culture. Rat 3Y1, SR-3Y1, T-47D, HL-60, K-562, U937, H9, HPB-ALL, Jurkat, 1Zaji, and Cos-1 cell lines were obtained from American Type Culture Collection (Rockville, MD) and grown in DMEM or R.PMI 1640 medium supplemented with heatinactivated FCS, 2 mM L-glutamine, and gentamycin (50 ~g/ ml). Peripheral T cells and B cells were isolated from healthy donors as described previously (10) . Fresh normal thymocytes were obtained from thymuses removed from patients at corrective cardiac surgery. A portion of thymus was finely minced, and a single-cell suspension was prepared by pressing the fragments through a stainless steel mesh. RBCs and debris were removed by centrifugation over Ficoll-Paque (Pharmacia LKB, Uppsala, Sweden), and then thymocytes were washed three times.
GST Fusion Proteins.
Plasmids coding glutathione-S-transferase (GST) fusion proteins were constructed by the insertion of human FAK cDNA fragments into pGEX-3X or pGEX-2TK (Pharnaacia LKB). GST-COOH-terminal domain (CT) contains FAK amino acid residues from 706 to 1,052, GST-AH contains amino acid residues from 706 to 904, and GST-H1 contains residues from 896 to 1,052 (20) . GST-AblSH2 was provided by Dr. Wayne G. Haser (Dana-Farber Cancer Institute, Boston, MA) (21) . GST-CrkSH2 and GST-NckSH2 were provided by Dr. Bruce J. Mayer (Children's Hospital, Boston, MA) (22) . GSTLckSH2 and GST-ShcSH2 were provided by Dr. Gotz Baumann (Sandoz Pharma LTD., Basel, Switzerland) (23). GST-SHPTP2SH2 was obtained from Dr. Benjamin G. Neel (Beth Israel Hospital, Boston, MA) (21). GST-PI3KSH2 was obtained from Dr. Brian Schaffhausen (Tufts University School of Medicine, Boston,/VIA) (21) . GST-Grb2SH2 was constructed from human Grb2 cDNA, which was obtained from Dr. Takeshi Urano (Tufts University School of Medicine, Boston, MA). GST-CskSH2 was generated from Csk cDNA, which was obtained from Dr. Masato Okada (Institute for Protein Research, Osaka University, Osaka, Japan). GSTPLCySH2 was generated by reverse transcription PCP-.
ImmunoblottingandImmunopredpitations. H9 cells were washed three times, resuspended in Iscove's serum-free media, incubated in plates coated with poly-L-lysine (PLL; Sigma Chemical Co., St. Louis, MO) or human plasma fibronectin (FN; GIBCO BRL, Gaithersburg, MD), and then solubilized in a modified NP-40 lysis buffer (1% NP-40, 0.5% deoxychofic acid, 150 mM NaC1, 50 nflVl Tris-HC1, 5 mM EDTA, 1 mM PMSF, 10 mM iodoacetamide, 1 txg/ml pepstatin A, 10 mM sodium fluoride, 10 mM sodium pyrophosphate, and 0.4 mM sodium vanadate, pH 8.0) or 1% digitonin lysis buffer, which contained 1% digitonin (Wako Pure Chemical Industries Ltd., Osaka, Japan) instead of NP-40 and deoxycholic acid. For immunoprecipitation, cell extracts were incubated with primary antibodies for 1 h at 4~ followed by additional incubation with goat anti-mouse IgG-conjugated agarose (Sigma Chemical Co.) or rabbit anti-mouse lgG (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) plus protein A-Sepharose (Pharmacia LKB) for 1 h at 4~ Specific mAbs against Cas, Crk, pp125FAK, Nck, paxillin, and SHPTP2 were purchased from Transduction Laboratories (Lexington, KY). Otherwise, cell extracts were incubated with glutathione Sepharose (Pharmacia LKB), which was conjugated with GST-fusion proteins for 1 h at 4~ Beads were washed with 1% NP-40 washing buffer (1% NP-40, 50 mM Tris-HCl, 140 mM NaC1, 2.5 mM EDTA) five times. For sequential immunoprecipitations, washed beads were boiled 5 rain at 100~ in the presence of 2% SDS, and the supernatants were reprecipitated with antibodies in the 1% NP-40 lysis buffer containing 0.1% final SDS concentration. For immunoblotting, samples were fractionated by 7% SDS-PAGE under reducing conditions and electro-transferred onto nitrocellulose membranes. Membranes were analyzed by immunoblotting with a chemiluminescence reagent (DuPont NEN, Boston, MA) after incubation with primary Ab and horseradish peroxidase-conjugated anti-mouse lgG (Amersham Corp., Arlington Heights, IL). Otherwise, membranes were incubated with T2q-labeled antiphosphowrosine mAb (4G10; Upstate Biotechnology, Inc., Lake Placid, NY) (10).
Overlay Assay. For the overlay assay, pGEX-2TK fusion protein containing FAK residues 707-1,052 (GST-CT) was phosphorylated in vitro using bovine heart muscle kinase (Sigma Chemical Co.) and [2/32p]ATP (DuPont NEN). Proteins transferred to the membrane were denatured in 6 M guamdine-HC1 and subsequently renatured (24) . This membrane was hybridized with 32p-labeled GST-FAK fusion protein in buffer containing 20 mM Hepes, pH 7.7, 75 mM KCI, 0.1 mM EDTA, 2.5 mM MgCI2, 1% nonfat dry milk, and 0.05% NP-40.
Molecular Bielogy. A kgt11 cDNA library constructed from human lymphoma Hut78 RNA (CLONTECH, Palo Alto, CA) was screened by anti-Cas mAb (Transduction Laboratory) and alkaline phosphatase-conjugated goat anti-mouse IgG (Sigma Chemical Co.) (25) . DNA sequencing was performed by the dideoxy nucleotide method (25, 26) . Isolated cDNA was inserted into pcDL-S1La for the transfection study in Cos-I cells (27) . pcDLSRa-LckY505F was generated from DNA provided by Dr. Roger M. Perlmutter (University of Washington, Seattle, WA). pMT3-SrcY527F was provided by Dr. Takeshi Urano. pMT3-EE-CrkI and II were constructed from chicken Crk genes, which were provided by Dr. Bruce J. Mayer. Cos-I cells were used for the transfection study by the DEAE-dextran method (25) . For Northern blotting, a DNA fragment of isolated cDNA (nucleotides 1,446-1,773) was 32p labeled and used as a probe (26) .
Results
Association of ppl05 with the COOH-terminal Domain of YAK. In our previous Study, we demonstrated that ppl05 and pp125FAK were tyrosine phosphorylated by [31 integrin stimulation via similar kinetics in H9 cells, although ppl05 is a distinct molecule from pp125FAK (12) . Because pp125FAK is an essential tyrosine kinase for [31 integrinmediated protein tyrosine phosphorylation, we attempted to define the relationship between pp125FAK and ppl05.
For this purpose, H9 cells were incubated with FN-or PLL-coated plates before cell lysis. H9 cell lysates were precipitated with GST fusion protein of the pp125FAK C O O Hterminal domain and analyzed by immunoblotting with antiphosphotyrosine mAb (anti-pTyr). As shown in Fig. 1 A, a tyrosine phosphorylated 105-kD protein precipitated on the beads conjugated with GST-CT from FN-stimulated cell lysate (lane 6), whereas this protein did not precipitate on GST-conjugated beads (lane 4). This tyrosine phosphorylated protein migrated at the same position as ppl05 in FN-incubated cell lysate (lane 2) and was detected only minimally in PLL-incubated cell lysate (lane 5). These results strongly suggest that ppl05 binds to the CT of pp125FAK. Paxillin was also precipitated from H9 cell lysate and was detected by anti-pTyr as a 70-kD band (lane 6), as we reported in HPB-ALL and T-47D cells (20) . To determine whether ppl05 binds to FAK or paxillin, H9 cell lysates were precipitated with deletion mutants of GST-CT. As shown in Fig. 1 B, ppl05 was precipitated with GST-AH, but not with GST-H1. Conversely, Paxillin was precipitated with GST-H1 but not with GST-AH. These results demonstrate that ppl05 binds to the FAK sequence that contains amino acid residues 706-904. This ppl05-binding domain of FAK is distinct from the paxillin-binding domain of FAK, indicating that ppl05/FAK binding is not mediated via paxillin.
Identification of ppl05 as a Cas-related Protein. ppl05 was precipitated with the GST-FAK fusion protein from FNstimulated H9 cell lysates and was detected by immunoblotting with anti-pTyr. A 130-kD tyrosine-phosphorylated protein was precipitated with the GST-FAK fusion protein from human breast cancer-derived T-47D cell lysates (Tachibana, K., and T. Sato, unpublished data). We identified this 130-kD protein as p130Cas using anti-Cas mAb (Transduction Laboratories) (Tachibana, K., and T. Sato, unpublished data). Recently, Polte and Hanks (19) reported that p130Cas bound to FAK by its SH3 domain. FAK residues 706-904, which were sufficient for ppl05 binding, contained the reported p130Cas-binding site. We attempted to determine ifppl05 was reactive with anti-Cas mAb. As shown in Fig. 2 A, a 105-kD protein was precipitated with the GST-FAK fusion protein and detected by immunoblotting with anti-Cas mAb (Transduction Laboratory) (anti-Cas blot, lanes 3 and 4). This 105-kD protein showed the same migration in SDS-PAGE as ppl05, which was precipitated by the GST-FAK fusion protein and detected by reblotting with anti-pTyr. We further performed a second immunoprecipitation with anti-Cas mAb after precipitation with the GST-FAK fusion protein. As shown in Fig. 2 A, a 105-kD Cas protein was precipitated first by the GST-FAK fusion protein and reprecipitated by anti-Cas mAb (anti-Cas blot). This 105-kD protein showed increased tyrosine phosphorylation by FN stimulation (Fig. 2 A, antipTyr blot, lanes 5 and 6). To confirm that ppl05 is the molecule recognized by anti-Cas mAb, H9 cell lysates were immunoprecipitated with anti-Cas mAb or anti-pTyr and analyzed by immunoblotting. As shown in Fig. 2 B, the 105-kD protein that was precipitated with anti-Cas mAb p130Cas has been reported to migrate as discrete species of 115 and 125 kD in SDS-PAGE (designated by Sakai et al. [13] as Cas-A and Cas-B, respectively) in rat fibroblast 3Y1 cells (also shown in Fig. 3 ). However, a decrease in the size of Cas-A and the simultaneous appearance of a broad 130-kD Cas band (designated Cas-C) were observed in both v-Srcand v-Crk-transformed 3Y1 cells. Because phosphorylated tyrosine residues were found predominantly in Cas-C, Cas-C appeared to be a modified form of Cas-A or Cas-B as the result oftyrosine phosphorylation (13) . We identified ppl05 in H9 cells as a putative Cas-related protein, ppl05 was originally identified as a 105-kD pro- tein that was tyrosine phosphorylated by the stimulation of [31 integrins. By i m m u n o b l o t t i n g with anti-pTyr, p p l 0 5 was detected predominantly in H9 cells as well as in peripheral T cells (11) , whereas p p l 0 5 was n o t detected well in the other T cell lines. T o determine the distribution of p p l 0 5 and p130Cas, we examined the expression and the mobility in S D S -P A G E of Cas proteins in various cell lines. As shown in Fig. 3 , using the same a m o u n t of whole extract from each cell line, Cas proteins with mobilities similar to Cas-A and Cas-B from 3Y1 cells were detected in h u m a n breast cancer T -4 7 D cells, although Cas proteins in T -4 7 D cells showed slightly faster migration. Cas proteins of similar mobility to Cas-A protein of T -4 7 D were also detected in h u m a n myelogeneous cell lines HL-60 and K562. O n the other hand, p p l 0 5 that showed a distinct mobility from Cas-A and Cas-B was detected in h u m a n myelogeneous cell line U937 and in h u m a n T lymphoblastold cell lines H9, HPB-ALL, and Jurkat, and in h u m a n B lymphoid cell line Raft. ppl05 was also detected in human thymocytes and in human peripheral T and B cells. The expression level of ppl05 varied widely among cells. ppl05Cas was significantly overexpressed in H9 cells, followed by peripheral T and B cells, thymocytes, and Kaji cells. A 110-kD Cas protein that migrated more slowly than ppl05 but faster than Cas-A of T-47D cells was also detected in H9 cells, thymocytes, and peripheral T cells. These findings indicate that ppl05 is a Cas-related protein that is expressed in lymphocytes.
cDNA Cloning ofpp 105. To further determine the structure of ppl05, we screened the hgt11 cDNA library derived from a human T lymphoblastoid cell line with antiCas mAb. Nucleotide sequences of three independent clones had homology with p130Cas. These three clones were cDNAs of an identical transcript, and the nucleotide sequences contained an open reading frame of 834 amino acids. The deduced amino acid sequence of this transcript showed conserved motifs with p130Cas, one SH3 domain in the NH2-terminal region, and multiple putative binding sites of the SH2 domains (Fig. 4 A) . Most of the SH2-binding motifs in the substrate domain are YXXP (YDXP), which are putative binding sites for Crk, Nck, and Abl SH2 domains (21) . Despite the conserved motifs, homology between p130Cas and the deduced amino acid sequence of this cDNA is relatively low (Fig. 4 B, 78% in the SH3 domain, 32% in the substrate domain, 30% in the specific domain, and 52% in the CT). Homology with another Cas-related protein, Efs (28) , is also relatively low (Fig. 4 B) . These results indicate that the cDNA encodes a novel Casrelated protein.
To determine whether this cDNA of a novel Cas-related protein encodes ppl05, the cDNA was inserted into an expression vector and transfected into Cos-1 cells. Cellular lysates from transfectants were analyzed by immunoprecipitation and immunoblotting. As shown in Fig. 5 A, antiCas mAb-reactive peptides that migrated at 105 and 110 kD in SDS-PAGE were detected (lanes 3 and 7). ppl05 from H9 cells (lanes 1 and 5) comigrated with a 105-kD peptide detected in the lysate from the transfectant and a slightly slower migrating Cas protein of 110-kD in H9 cells comigrated with a 110-kD peptide. Both Cas proteins detected in H9 cells showed faster migration than Cas proteins in T-47D (lanes 4 and 8) and Cos-1 cells (lanes 2 and 6) . This result strongly suggests that (a) the Cas-related gene encodes ppl05 and (b) a 110-kD Cas protein detected in H9 cells is the protein product of the same transcript as ppl05, despite a different mobility in SDS-PAGE (similar to that observed with p130Cas-A and Cas-B).
p130Cas was highly phosphorylated on tyrosine residues in v-Src-or v-Crk-expressing cells (13) . To determine whether ppl05 is tyrosine phosphorylated by these stimulations, an expression vector containing ppl05 was cotransfected in Cos-1 cells, with expression vectors containing activated Src family kinases or Crk. ppl05 was then precipitated by anti-Cas mAb and analyzed by immunoblotting with anti-pTyr. As shown in Fig. 5 B, ppl05 was highly phosphorylated on tyrosine residues by the cotransfection of Src, Lck, CrkI, or CrklI (lanes 3-6, respectively). Next, to identify whether tyrosine-phosphorylated ppl05 binds to Crk, lysates of ppl05-transfected Cos cells were immunoprecipitated with anti-Crk mAb and analyzed by immunoblotting with anti-Cas mAb. ppl05 was coprecipitated with Crk only in Cos cells that coexpressed activated Lck (Fig. 5 B, lane 8) . Furthermore, ppl05 was coprecipitated with EE-tagged CrkII (lane 9). These results demonstrate that tyrosine-phosphorylated ppl05 binds to Crk proteins in vivo.
Expression of the pp l 05 Transcript. Using anti-Cas mAb, we showed cell type-specific expression ofppl05. To further investigate the expression of ppl05 in different cell types, expression ofppl05 m R N A was analyzed by Northern blotting. As shown in Fig. 6 A, 5.2-and 3.0-kb RNAs were detected in H9 cell polyA + 1LNA using 32p-labeled ppl05 cDNA fragment as a probe. This ppl05 cDNA fragment expressed the lowest homology with p130Cas. The 5.2-kb R.NA comigrated with 28S ribosomal 1LNA and was detected as a shifted band in Northern blotting with total RNA. A smaller amount of ppl05 transcript was detected in peripheral T cells, and none was detected from 3Y1 and T-47D cells. A similar analysis was performed with RNAs from various tissues. As shown in Fig. 6 B, ppl05 was expressed in most tissues including spleen and thymus, although ppl05 was weakly detected in brain and liver. This result indicates that ppl05 transcript is ubiquitously expressed, whereas the ppl05 protein is detected only in lymphocytes among the cells investigated.
Identification of the pp l O 5-binding Proteins.
To further define the nature of ppl05, we investigated ppl05-binding proteins. As described previously, ppl05 binds to FAK in vitro. To further characterize ppl05-FAK binding, ppl05 was precipitated from H9 cell lysates with anti-Cas mAb and analyzed by the overlay assay with a labeled GST-FAK A ggg ctg cga ctg aca agc ggc tct caa tgg a~ ggc ggg cac cgc m~ caa ccc acc gct gcc gaa atg aag H K gtc Cca gag tgt gcc gag gaa ctg tag aac ace ggg qga ctg gaa gga 
tcc cca gct tag qac aaa egg ctc ctg att ggr ccc atg cag gag act. gcc tcc agt cac 360 
aag tag ctc ace ace ace ate aac ace aac gca gag 1800
c t g ccc cca ggc c t g agc aag gag cag gcc o c t gac 1880
caa cag aaa gag c t a t t g gaa aaa gag a a t arc aug 2100 , and total cellular RNAs were isolated by the method described (26) . Northern blot analysis with a 32p-labeled ppl05 cDNA fragment was performed by the method described (26) . (B) Tissue distribution of ppl05 was determined by Northern blotting with human tissue blots (Clontech) and the ppl05 probe described above.
fusion protein. As shown in Fig. 7 A, 105-and l l0-kD proteins were detected with labeled GST-FAK fusion protein, indicating that both ppl05 and p110-kD Cas protein directly bind to FAK. Another FAK-binding protein, paxillin, was also detected, as reported previously (20) . To investigate the binding of ppl05 to pp125FAK in vivo, coprecipitation analysis using anti-FAK mAb was performed.
As shown in Fig. 7 B, lanes 7 and 8, ppl05 was coimmunoprecipitated with pp125FAK from H9 cell lysates, indicating in vivo association between ppl05 and pp125FAK. This pp105-pp125FAK association appears to be unaffected by [31 integrin stimulation or subsequent tyrosine phosphorylation of both proteins, because coprecipitated ppl05 showed no quantitative difference between FNstimulated and unstimulated cells. Next, we attempted to define the proteins that were recruited to ppl05 in a phosphorylated tyrosine residuedependent manner. For this purpose, lysates from FN-stimulated H9 cells were precipitated with GST fusion proteins that contained SH2 domains from various proteins and analyzed by immunoblotting with anti-Cas mAb and antipTyr. As shown in Fig. 7 C, 110-105 -kD tyrosine-phosphorylated proteins were precipitated with GST fusion proteins ofc-Abl, Crk, Csk, Grb2, Lck, Nck, and SHPTP2 SH2 domains (anti-pTyr blot), ppl05 was precipitated by GST-AblSH2, GST-CrkSH2, and GST-NckSH2, whereas ppl05 was weakly precipitated by GST-LckSH2, GST-SHPTP2SH2, and GST-CskSH2 (anti-Cas blot). To determine whether the binding of ppl05 to these GST fusion proteins was induced by [31 integrin stinmlation, a similar analysis was performed by using lysates of H9 cells that were incubated in PLL-or FN-coated plates. As shown in Fig. 7 D, enhancement of ppl05 precipitation was observed in the lanes of GST-SH2 domain fusion proteins of c-Abl, Crk, and Nck, whereas increased but slight amounts of ppl05 were detected in the lanes of the GST-SH2 domain fusion proteins of Lck and SHPTP2. These results indicated that tyrosine-phosphorylated ppl05 binds to SH2 domains of c-Abl, Crk, Lck, Nck, and SHPTP2 in vitro.
To further determine if these ppl05-binding proteins bind to ppl05 in vivo, coimmunoprecipitation analysis o f p p l 0 5 with these proteins was performed. As shown in Fig. 7 E, ppl05 was coprecipitated with Crk and Nck, whereas ppl05 was weakly coprecipitated with SHPTP2. Unlike pp125FAK-pp105 binding, ppl05 that was coprecipitated with Crk, Nck, or SHPTP2 was increased by [31 integrin stimulation with FN. These results indicate that [31 integrin stimulation leads to the recruitment of various proteins, including Crk, Nck, and SHPTP2, to the tyrosine-phosphorylated ppl05, in addition to stimulation-independent association with pp125FAK. These protein-protein interactions further suggest the putative function ofppl05 in the 131 integrin-mediated signaling pathways.
Discussion
We reported previously that the engagement of [31 integrins induced tyrosine phosphorylation of a 105-kD protein (ppl05) in H9 cells and peripheral T cells (10) (11) (12) . ppl05 was one of the major proteins in T cells that was tyrosine phosphorylated by [31 integrin stimulation. In this study, we identified ppl05 as a tyrosine-phosphorylated 4, 6, 8, 10, 12, 14, I6, and 18 and lanes I, 3, 5, 7, 9, 1I, 13, 15, 17, and 19, respectively) . After lysis, cellular lysates were precipitated with GST-(lane 1), GST-AblSH2-(lanes 2 and 3), GST-CrkSH2-(lanes 4 and 5), GST-CskSH2 (lanes 6 and 7), GST-Grb2SH2- (lanes 8 and 9) , GST-LckSH2-(lanes I0 and 1 I), GST-NckSH2- (lanes 12 and 13) , GST-PI3KSH2-(hues 14 and 1~, GST-ShcSH2- (lanes 16 and 17) , and GST-SHPTP2SH2- (lanes 18 and 19) (11, 12, 18, 19) . Both p p l 0 5 and p130Cas are tyrosine phosphorylated by the cotransfection o f activated Src or Crk, and both bind to Crk in a tyrosine p h o s p h o r y l a t i o ndependent m a n n e r (13) . Structurallyl the deduced amino acid sequence o f each Cas protein contains one highly c o nserved SH3 domain and multiple binding sites for SH2 d omains. T h e SH3 domain o f Cas is the FAK binding site (19; Tachibana, K., unpublished data), p p l 0 5 contains 13 repeated Y X X P motifs (7 Y D X P motifs) in the substrate domain, whereas pl30Cas contains 15 repeated YXXP motifs (9 YDXP motifs) (13) . The other Cas family protein, p83Efs, contains 8 repeated YXXP motis (4 YDXP motifs) (28) . These motifs are reported to be the putative binding sites of the SH2 domains of Crk, Nck, and Abl (21) . In addition, each Cas protein contains one conserved YDYVHL motif in the CT. This motif is weakly homologous to the predicted binding sites of the Src SH2 domain and of the SHPTP2 SH2 domain, although the protein(s) that binds to this motif has not yet been determined. The CT is relatively conserved among these three Cas proteins, suggesting that this domain has an important function(s) common to Gas proteins.
Besides these conserved motifs, there is one motif that is not conserved in ppl05, p130Cas and p83ER contain prolinerich sequences (RPLPXPP) upstream from the YDYVHL motif, although ppl05 does not contain these sequences. These sequences have been reported to be putative SH3 domain-binding sites, and p83Efs was originally cloned as a Fyn SH3 domain-binding protein (28) . This difference in structure may result in the difference between protein interactions and in the difference in function between ppl05 and the other Cas family proteins.
The largest difference between ppl05 and p130Cas was the cell type distribution. We previously identifed ppl05 in human T lymphocytes (11), whereas Sakai et al. (13) identified p130Cas in fibroblasts. In this study, we demonstrated the expression of Cas proteins in various cell lines. p130Cas was predominantly expressed in a human breast cancer cell line, T-47D, as well as in rat fibroblast 3Y1. ppl05 was predominantly expressed in human lymphocytes. However, Northern blotting with tissue RNAs showed ubiquitous distribution of ppl05, suggesting that the expression of ppl05 is not limited to lymphocytes, p130Cas transcript was reported to be ubiquitously expressed, especially in the brain, lung, intestine, kidney, and testis (13) . On the other hand, another Cas family protein, p83Efs, was reported to be expressed in the embryo, placenta, brain, and skeletal muscle but not in the spleen (28) . These results indicate that ppl05 is the dominant Cas protein in lymphocytes, whereas p130Cas is the dominant Cas protein in fibroblasts. In addition to this reciprocal expression, ppl05 RNA is not well expressed in brain and liver. This interesting observation may suggest the putative function and/or promoter specificity ofppl05.
Based on the notion that ppl05 is a p130Cas-related protein, we attempted to define the putative function of ppl05. Because ppl05 is tyrosine phosphorylated by [31 integrin stimulation in H9 cells and in peripheral T lymphocytes, it is conceivable that phosphorylated tyrosine residues of ppl05 are involved in the transduction of ]31 integrin-mediated signals. If so, how is ppl05 tyrosine phosphorylated by the stimulation of ]31 integrins? We reported previously that ppl05 was tyrosine phosphorylated with similar kinetics to pp125FAK phosphorylation by FN stimulation in H9 cells (12) . The presence of pp105-pp125FAK binding suggests the involvement of FAK in the [31 integrin-mediated tyrosine phosphorylation of ppl05, because FAK itself is activated and autophosphorylated by [31 integrin stimulation (29) . It has also been reported that autophosphorylated FAK bound to Src SH2 domain and formed a stable complex (30) , and cotransfected Src family tyrosine kinases have been shown to phosphorylate ppl05. Taken together, these observations suggest that pp125FAK itself, and/or FAK-associated Src-family kinases, are involved in integrin-mediated tyrosine phosphorylation of ppl05.
The second question to be considered is how tyrosinephosphorylated ppl05 transduces downstream signals. Because one of the major functions of protein tyrosine phosphorylation is phosphorylated tyrosine-mediated protein-protein interaction, we investigated proteins that were recruited to ppl05 by [31 integrin stimulation. We demonstrated that Crk and Nck were recruited to Wrosine-phosphorylated ppl05 both in vivo and in vitro. SHPTP2 was also recruited, although this association was weak. These proteins, which are recruited to ppl05, appear to be involved in [31 integrin signaling via their recruitment to ppl05. ppl05 contains multiple putative binding sites for the Crk SH2 domain, and tyrosine-phosphorylated ppl05 binds to Crk. Crk is an adapter protein composed of SH2 and SH3 domains. Crk binds to SOS and another guanine nucleotide exchange protein, C3G, through its SH3 domain. Recently, our and several other laboratories reported that [31 integrin stimulation induces activation of Erk (10, 31, 32) . Crk was reported to be involved in Ras activation by the recruitment of SOS (14) . Tyrosine-phosphorylated ppl05 may be involved in the recruitment of SOS via Crk, and recruited SOS activates Ras and Erk (33) . However, Crk has been reported to bind to C3G better than to SOS, and membrane-anchored C3G activated another small GTPase, RaplA/K-revl, which inhibited Ras-mediated signals by competition (34) . These reports suggest that recruitment of Crk to tyrosine-phosphorylated ppl05 may be involved in the regulation of Erk signals through Ras and Rap1A.
Nck is another adapter protein that contains three SH3 domains and one SH2 domain (35) . It has been reported that overexpression of Nck resulted in oncogenic transformation in fibroblasts (35) , although the native function of Nck has not yet been identified. However, ppl05 contains multiple putative binding sites for the Nck SH2 domain, and tyrosine-phosphorylated ppl05 recruited Nck. These findings strongly suggest the involvement of Nck in [31 integrin-mediated signaling.
SHPTP2 is a cytoplasmic tyrosine phosphatase with two SH2 domains (36) . Recently, it was reported that a dominant-negative SHPTP2 mutant inhibited the insulindependent dephosphorylation of FAK (37) . SHPTP2 is recruited to tyrosine-phosphorylated ppl05 through its own SH2 domain, and the deduced amino acid sequence of ppl05 contains a possible binding site for the SHPTP2 SH2 domain. This recruitment of SHPTP2 to ppl05 could be involved in the dephosphorylation of FAK and ppl05.
ppl05, as well as p130Cas, is tyrosine phosphorylated by the overexpression of Crk proteins. Since Crk itself does not contain a catalytic domain characteristic of protein tyrosine kinases, overexpressed Crk may recruit a tyrosine kinase(s) to ppl05, c-Abl is known to bind to the Crk SH3 domain (38) and was reported to phosphorylate tyrosine residues of p130Cas in vitro (39) . In addition, tyrosine-phosphorylated ppl05 bound to the c-Abl SH2 domain in vitro. Unfortunately, we have been unable to demonstrate in vivo binding of ppl05 to c-Abl. However, findings described above suggest that c-Abl may interact and phosphor/late ppl05 directly or via the binding to Crk. In summary, ppl05, one of the major tyrosine phosphorylated proteins induced through the ligation of [31 integrin on the surface of lymphocytes, is identified as a novel p130Cas-related protein, ppl05 is the major Cas protein in lymphoid cells, whereas p130Cas is the major Cas protein in fibroblasts, ppl05 is directly associated with the FAK COOH-terminal region in an integrin stimulation-independent manner, and tyrosine phosphorylated ppl05 binds to the SH2 domains of Crk, Nck, and SHPTP2 in T cells. These findings reveal a novel architecture of [M integrinmediated protein tyrosine phosphorylation and further suggest the involvement of Crk, Nck, and SHPTP2 in the downstream pathways of131 integrin-mediated signaling.
